Tarbox Family Office’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-20
| Closed | -$3K | – | 150 |
|
|
2022
Q1 | $3K | Hold |
20
| – | – | ﹤0.01% | 647 |
|
|
2021
Q4 | $3K | Hold |
20
| – | – | ﹤0.01% | 736 |
|
|
2021
Q3 | $4K | Hold |
20
| – | – | ﹤0.01% | 679 |
|
|
2021
Q2 | $3K | Sell |
20
-11
| -35% | -$1.65K | ﹤0.01% | 770 |
|
|
2021
Q1 | $4K | Hold |
31
| – | – | ﹤0.01% | 608 |
|
|
2020
Q4 | $4K | Hold |
31
| – | – | ﹤0.01% | 569 |
|
|
2020
Q3 | $5K | Hold |
31
| – | – | ﹤0.01% | 470 |
|
|
2020
Q2 | $5K | Hold |
31
| – | – | ﹤0.01% | 467 |
|
|
2020
Q1 | $3K | Buy |
31
+11
| +55% | +$1.07K | ﹤0.01% | 505 |
|
|
2019
Q4 | $2K | Hold |
20
| – | – | ﹤0.01% | 755 |
|
|
2019
Q3 | $2K | Hold |
20
| – | – | ﹤0.01% | 689 |
|
|
2019
Q2 | $1K | Hold |
20
| – | – | ﹤0.01% | 880 |
|
|
2019
Q1 | $2K | Hold |
20
| – | – | ﹤0.01% | 482 |
|
|
2018
Q4 | $1K | Hold |
20
| – | – | ﹤0.01% | 534 |
|
|
2018
Q3 | $2K | Hold |
20
| – | – | ﹤0.01% | 490 |
|
|
2018
Q2 | $2K | Hold |
20
| – | – | ﹤0.01% | 477 |
|
|
2018
Q1 | $2K | Hold |
20
| – | – | ﹤0.01% | 486 |
|
|
2017
Q4 | $3K | Hold |
20
| – | – | ﹤0.01% | 435 |
|
|
2017
Q3 | $2K | Hold |
20
| – | – | ﹤0.01% | 472 |
|
|
2017
Q2 | $2K | Hold |
20
| – | – | ﹤0.01% | 458 |
|
|
2017
Q1 | $1K | Hold |
20
| – | – | ﹤0.01% | 522 |
|
|
2016
Q4 | $1K | Buy |
+20
| New | +$1K | ﹤0.01% | 487 |
|
|
2016
Q2 | – | Sell |
-10
| Closed | -$1K | – | 556 |
|
|
2016
Q1 | $1K | Buy |
+10
| New | +$1K | ﹤0.01% | 482 |
|